Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?

Intensive Care Med. 2010 May;36(5):729-31. doi: 10.1007/s00134-010-1771-2. Epub 2010 Feb 4.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / etiology
  • Piperazines / therapeutic use*
  • Purines / therapeutic use
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / drug therapy*
  • Sildenafil Citrate
  • Sulfones / therapeutic use*
  • Vasodilator Agents / therapeutic use*

Substances

  • Piperazines
  • Purines
  • Sulfones
  • Vasodilator Agents
  • Sildenafil Citrate
  • 3',5'-Cyclic-GMP Phosphodiesterases